tiprankstipranks
Vext Science Foresees Growth with Ohio’s Cannabis Program
Company Announcements

Vext Science Foresees Growth with Ohio’s Cannabis Program

Story Highlights

Vext Science (TSE:VEXT) has released an update.

Don't Miss Our Christmas Offers:

Vext Science, Inc. has reported a revenue of $8.4 million and an adjusted EBITDA of $1.1 million for Q2 2024. Poised for growth with a significant footprint in Ohio, Vext anticipates a revenue surge following the state’s adult-use cannabis program launch. The company’s strong position in the market is supported by its comprehensive Ohio network, including cultivation, manufacturing facilities, and retail dispensaries.

For further insights into TSE:VEXT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskVext Science Gains Strong Shareholder Support
TipRanks Canadian Auto-Generated NewsdeskVext Science Expands Retail Footprint with New Ohio Dispensary
TipRanks Auto-Generated NewsdeskVext Science Reports Strong Q3 2024 Financial Performance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App